1 / 1

What is Sanfilippo disease type C?

Raising Awareness of the Rare Disease Sanfilippo Syndrome C Using The Open Drug Discovery Teams (ODDT) Mobile App Sean Ekins 1 , Alex M. Clark 2 and Jill Wood 3

ivria
Download Presentation

What is Sanfilippo disease type C?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Raising Awareness of the Rare Disease Sanfilippo Syndrome C Using The Open Drug Discovery Teams (ODDT) Mobile App Sean Ekins1 , Alex M. Clark2 and Jill Wood3 1 Collaborations in Chemistry, 5616 Hilltop Needmore Road, Fuquay Varina, NC 27526, U.S.A., 2Molecular Materials Informatics, 1900 St. Jacques #302, Montreal, Quebec, Canada H3J 2S1., 3Jonah's Just Begun, P.O. Box 150057, Brooklyn, NY 11215, USA What is Sanfilippo disease type C? Mucopolysaccharidosis Type IIIC (MPS IIIC or Sanfilippo disease type C) is one such LSD that is caused by deficiency of enzyme heparan sulfate acetyl CoA: a-glucosaminide N-acetyltransferase, (HGSNAT) responsible for degradation of heparan sulfate, a repeating carbohydrate generally found attached to proteoglycans. The clinical phenotype includes onset in infancy or early childhood, progressive and severe neurological deterioration causing hyperactivity, sleep disorders and loss of speech accompanied by behavioral abnormalities, neuropsychiatric problems, mental retardation, hearing loss, and visceral manifestations, such as mild hepatomegaly, joint stiffness, vertebral bodies and hypertrichosis. There is no treatment but there are research efforts to find one funded primarily by multiple MPSIIIC disease foundations. The number of patients and research community engaged are both small. The amount of research funding available is limited so any efforts to raise awareness of this disease are key. We now present the Open Drug Discovery Teams (ODDT) project which uses a free iOS mobile app as user entry point http://tinyurl.com/ato62ko. The app has a magazine-like interface, and server-side infrastructure for hosting chemistry-related data as well as value added services. The project is open to participation from anyone and provides the ability for users to make annotations and assertions, thereby contributing to the collective value of the data to the engaged community. The infrastructure for the app is currently based upon the Twitter API and uses Google Alerts RSS feeds as a useful proof of concept for a real time source of publicly generated content. We now highlight how ODDT can be used to raise awareness of Sanfilippo syndrome and engage this disease community by following #sanfilipposyndrome using Twitter and Google Alerts. Reference Ekins S, Clark AM and Williams AJ,Open Drug Discovery Teams: A Chemistry Mobile App for Collaboration, Mol Informatics, Aug;31(8):585-597, 2012 Raise awareness of clinical studies Information on rare disease advocacy @jonahsjustbegun and @collabchem tweets with #sanfilipposyndrome Content collected ready for viewing Content collected ready for viewing B Content from web The App Raise awareness of children with disease Share molecules and ideas for drug repurposing Highlight availability and cost of treatments for rare diseases Highlight and link to important published papers Links to other databases Items that are endorsed are saved to content tab Get ODDT here support it! http://collabchem.com

More Related